Released on = March 22, 2007, 10:01 am

Press Release Author = AnaSpec Inc.

Industry = Biotech

Press Release Summary = Continuing in its commitment to rapidly expand its antibody
offerings, AnaSpec, a leading provider of integrated proteomics solutions, added
eighty-two (82) new antibodies to its growing collection of catalog antibodies. The
targeted researchers areas for these antibodies include apoptosis, signal
transduction, cancer research, and a host of other applications.

Press Release Body = San Jose, CA - March 21, 2007

Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a
leading provider of integrated proteomics solutions, added eighty-two (82) new
antibodies to its growing collection of catalog antibodies. The targeted
researchers areas for these antibodies include apoptosis, signal transduction,
cancer research, and a host of other applications.

Ant-AES (CT) - Cat# 54226, 50 µg
Amino-terminal enhancer of split; GRG; ESP1; TLE5

Ant-AES (NT) - Cat# 54227, 50 µg
Amino-terminal enhancer of split; GRG; ESP1; TLE6

Anti-AIM / API6 (NT) - Cat# 54265, 50 µg
Apoptosis inhibitor of macrophages; API6; API6; SP alpha; CD5L

Anti-AIM / API6 (CT) - Cat# 54264, 50 µg
Apoptosis inhibitor of macrophages; API6; API6; SP alpha; CD5L

Anti-Akt1 - Cat# 54219, 50 µg
Protein kinase B; PKB

Anti-Anthrax EF - Cat# 54197, 50 µg
Anthrax edema factor

Anti-Anthrax LF (CT) - Cat# 54196, 50 µg
Anthrax lethal factor

Anti-Anthrax LF (IN) - Cat# 54195, 50 µg
Anthrax lethal factor

Anti-Anthrax PA (CT) - Cat# 54194, 50 µg
Anthrax protective antigen

Anti-Anthrax PA (IN) - Cat# 54193, 50 µg
Anthrax protective antigen

Anti-APG7 (CT) - Cat# 54230, 50 µg
Autophagy protein 7; ATG7

Anti-APG7 (NT) - Cat# 54231, 50 µg
Autophagy protein 7; ATG7

Anti-ASK1 (C2) - Cat# 53235, 50 µg
Apoptosis signal-regulating kinase 1; MAPKKK; MEK kinase 5

Anti-ASK1 (NT) - Cat# 54251, 50 µg
Apoptosis signal-regulating kinase 1; MAPKKK; MEK kinase 5

Anti-ATF6 (CT) - Cat# 54252, 50 µg
Activating transcription factor 6

Anti-ATR (CT) - Cat# 54131, 50 µg
Anthrax toxin receptor; tumor endothelial marker 8; TEM8

Anti-ATR (IN) - Cat# 54130, 50 µg
Anthrax toxin receptor; tumor endothelial marker 8; TEM8

Anti-BAG-1 / RAP46 (CT) - Cat# 54274, 50 µg
Bcl-2-binding athanogene-1; receptor-associated protein 46; RAP46

Anti-BAG-1 / RAP46 (NT) - Cat# 54275, 50 µg
Bcl-2-binding athanogene-1; receptor-associated protein 46; RAP46

Anti-BAP31 (CT) - Cat# 54250, 50 µg
B cell receptor-associated protein 31; BCR associated protein 31

Anti-Beclin-1 (CT) - Cat# 54228, 50 µg
Coiled-coil myosin-like Bcl-2-interacting protein

Anti-Beclin-1 (NT) - Cat# 54229, 50 µg
Coiled-coil myosin-like Bcl-2-interacting protein

Anti-Bfl-1 (CT) - Cat# 54276, 50 µg
Bcl-2-related protein A1; Hemopoietic-specific early response protein

Anti-Bfl-1 (NT) - Cat# 54277, 50 µg
Bcl-2-related protein A1; Hemopoietic-specific early response protein

Anti-Bif /endophilin B1 - Cat# 54266, 50 µg
Bax-interacting factor 1; endophilin B1

Anti-Bik / apoptosis inducer NBK - Cat# 54267, 50 µg
Bcl-2-interacting killer; apoptosis inducer NBK

Anti-Bim (Bod) (IN2) - Cat# 54191, 50 µg
Bod; Bcl-2 like 11

Anti-Bit1 (IN) - Cat# 54225, 50 µg
Bcl-2 inhibitor of transcription 1; Peptidyl-tRNA hydrolase 2

Anti-Bit1 (NT) - Cat# 54224, 50 µg
Bcl-2 inhibitor of transcription 1; Peptidyl-tRNA hydrolase 2

Anti-Caspase-1 (CT) - Cat# 54209, 50 µg
ICE; IL-1b converting enzyme

Anti-Caspase-1 (IN) - Cat# 54210, 50 µg
ICE; IL-1b converting enzyme

Anti-Caspase-2 (NT) - Cat# 54205, 50 µg
ICH-1; Nedd2

Anti-Caspase-4 (IN) - Cat# 54207, 50 µg
ICH-2; ICErelII; Mih1

Anti-Caspase-4 (NT)\\ - Cat# 54206, 50 µg
ICH-2; ICErelII; Mih1

Anti-Caspase-5 (IN) - Cat# 53296, 50 µg
ICH-3; ICErelIII

Anti-Caspase-5 (NT) - Cat# 54208, 50 µg
ICH-3; ICErelIII

Anti-Caspase-6 (IN) - Cat# 54213, 50 µg
Mch2

Anti-Caspase-6 (NT) - Cat# 53297, 50 µg
Mch2

Anti-Caspase-7 (CT) - Cat# 54211, 50 µg
ICELAP3; Mch3

Anti-Caspase-7 (NT) - Cat# 54212, 50 µg
ICELAP3; Mch3

Anti-Caspase-8 (CT) - Cat# 54214, 50 µg
FLICE; MACH; Mch5

Anti-Caspase-8 (IN) - Cat# 54215, 50 µg
FLICE; MACH; Mch5

Anti-Clusterin - Cat# 54272, 50 µg
Complement lysis inhibitor; CLI; Apolipoprotein J; ApoJ

Anti-Fn14 - Cat# 54284, 50 µg
Fibroblast growth factor-inducible 14; TNFRSF12; TWEAK-R

Anti-IRAK-4 - Cat# 54132, 50 µg
Interleukin-1 receptor-associated kinase-4; REN-6

Anti-IRE1p (IN) - Cat# 54247, 50 µg
Endoplasmic reticulum-to-nucleus signaling 1; ERN2

Anti-IRE1p (NT) - Cat# 54246, 50 µg
Endoplasmic reticulum-to-nucleus signaling 1; ERN1

Anti-LAMP-1 - Cat# 54235, 50 µg
Lysosome associated membrane protein 1

Anti-LAMP-2 - Cat# 54234, 50 µg
Lysosome associated membrane protein 2

anti-LSD1 - Cat# 54259, 50 µg
Lysine-specific histone demethylase; amine oxidase flavin containing domain protein
2; AOF2

Anti-Mcl-1 (CT) - Cat# 54216, 50 µg
Myeloid cell leukemia 1

Anti-Mcl-1 (IN) - Cat# 54218, 50 µg
Myeloid cell leukemia 1

Anti-Mcl-1 (NT) - Cat# 54217, 50 µg
Myeloid cell leukemia 1

Anti-MD-1 / Lymphocyte antigen 86 (IN) - Cat# 54271, 50 µg
Lymphocyte antigen 86

Anti-mIRAK2 (C2) - Cat# 54221, 50 µg
mouse interleukin-1receptor associated kinase 3

Anti-mIRAK2 (CT) - Cat# 54220, 50 µg
mouse interleukin-1receptor associated kinase 2

Anti-Pak2 (CT) - Cat# 54278, 50 µg
p21-activated kinase 2; PAK65

Anti-PIST (CT) - Cat# 54236, 50 µg
Golgi associated PDZ and coiled-coil motif containing; GOPC

Anti-PIST (IN) - Cat# 54237, 50 µg
Golgi associated PDZ and coiled-coil motif containing; GOPC

Anti-RIG-1 - Cat# 54285, 50 µg
Retinoic acid inducible gene 1 protein; RIG-I; Dead box protein 58; ddx58

Anti-RP105 / CD180 antigen precursor (CT) - Cat# 54268, 50 µg
Radioprotective 105; Lymphocyte antigen 64; CD180 antigen precursor

Anti-RP105 / CD180 antigen precursor (NT) - Cat# 54269, 50 µg
Radioprotective 105; Lymphocyte antigen 64; CD180 antigen precursor

Anti-SOCS1 (CT) - Cat# 54260, 50 µg
Suppressor of cytokine signaling 1; JAK-binding protein; JAB

Anti-SOCS1 (NT) - Cat# 54261, 50 µg
Suppressor of cytokine signaling 1; JAK-binding protein; JAB

Anti-TL1A - Cat# 54262, 50 µg
TNFSF15; Tumor necrosis factor (ligand) superfamily 15; VEGI

Anti-TLR1 (IN) - Cat# 54239, 50 µg
Toll-like receptor 1

Anti-TLR1 (NT) - Cat# 54238, 50 µg
Toll-like receptor 1

Anti-TLR3 (CT) - Cat# 54240, 50 µg
Toll-like receptor 3

Anti-TLR3 (NT) - Cat# 54241, 50 µg
Toll-like receptor 3

Anti-TLR5 (CT) - Cat# 54243, 50 µg
Toll-like receptor 5

Anti-TLR5 (IN) - Cat# 54242, 50 µg
Toll-like receptor 5

Anti-TLR6 (IN) - Cat# 54245, 50 µg
Toll-like receptor 6

Anti-TLR6 (NT) - Cat# 54244, 50 µg
Toll-like receptor 6

Anti-TLR9 (CT) - Cat# 54253, 50 µg
Toll-like receptor 9

Anti-TLR9 (IN) - Cat# 54254, 50 µg
Toll-like receptor 9

Anti-TRAF2 (CT) - Cat# 54248, 50 µg
TNF receptor-associated factor 2

Anti-TRAF2 (NT) - Cat# 54249, 50 µg
TNF receptor-associated factor 2

Anti-TRAF3 (NT) - Cat# 54223, 50 µg
TNF receptor-associated factor 3; CD40 binding protein; LMP1associated protein 1;
CD40BP; LAP1

Anti-TRAF3/1 (CT) - Cat# 54222, 50 µg
TNF receptor-associated factor 3; CD40 binding protein; LMP1associated protein 1;
CD40BP; LAP1

Anti-TWEAK - Cat# 54263, 50 µg
TNF-related weak inducer of apoptosis; TNF ligand superfamily member 12

Anti-UNG2 / UDG2 (NT) - Cat# 54273, 50 µg
Uracil-DNA glycosylase 2; UDG2

Anti-XAF-1 (IN) - Cat# 54192, 50 µg
XIAP associated factor 1

For more information visit www.anaspec.com

Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to
pharmaceutical, biotech, and academic research institutions throughout the world.
With a vision for innovation through synergy, AnaSpec focuses on three core
technologies: peptides, detection reagents, and combinatorial chemistry.
Established in 1993, AnaSpec\'s headquarters and manufacturing facilities are located
in San Jose, CA.


Web Site = http://www.anaspec.com

Contact Details = 2149 O\'Toole Ave.
San Jose, CA
408-452-5055
ping@anaspec.com